Article
Meta-analyses in Cancer Clinical Trials: Principles and Pitfalls
J. R. Benson MA, DM,
K. Saeb-Parsy MA, PhD,
Corresponding Author
J. R. Benson MA, DM
Cambridge Breast Unit, Addenbrooke’s Hospital, Hills Road, CB2 2QQ Cambridge, United Kingdom
[email protected]Search for more papers by this authorK. Saeb-Parsy MA, PhD
Department of Surgery, Addenbrooke’s Hospital, Hills Road, CB2 2QQ Cambridge, United Kingdom
Search for more papers by this authorJ. R. Benson MA, DM,
K. Saeb-Parsy MA, PhD,
Corresponding Author
J. R. Benson MA, DM
Cambridge Breast Unit, Addenbrooke’s Hospital, Hills Road, CB2 2QQ Cambridge, United Kingdom
[email protected]Search for more papers by this authorK. Saeb-Parsy MA, PhD
Department of Surgery, Addenbrooke’s Hospital, Hills Road, CB2 2QQ Cambridge, United Kingdom
Search for more papers by this author
References
- 1.Glass GV Primary, secondary, meta-analysis of research. Educat Res (1976) 5: 3–810.2307/1174772
10.2307/1174772 Google Scholar
- 2.Pocock SJ, Lagakos SW Practical experience of randomization in cancer trials: an international survey. Br J Cancer (1982) 46: 3687126426
- 3.Sacks HS, Barrier J, Reitman D et al. Meta-analyses of randomized controlled trials. N Engl J Med (1987) 316: 450380798610.1056/NEJM198702193160806
- 4.Yates F, Cochran WG The analysis of groups of patients. J R Stat Soc (1937) 4: 102–118
- 5.Chalmers TC, Matta RJ, Smith H et al. Evidence favouring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med (1977) 297: 1091–109690956610.1056/NEJM197711172972004
- 6. Fibrinolytic Therapy Trialists Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction. Lancet (1994) 343: 311
- 7. ISIS-1 (First International Study of Infarct Survival) Collaborative Group A randomized trial of intravenous atenolol amongst 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet (1986) 2: 57–66
- 8.Peto R Why do we need systematic overviews of randomized trials?. Stat Med (1987) 6: 233–2403616281
- 9.Hennekens CH, Buring JE, Hebert PR Implications of overviews of randomized trials. Stat Med (1987) 6: 397–4023616292
- 10.Chalmers TC, Leven H, Sacks HS et al. Meta-analysis of clinical trials as a scientific discipline. I: control of bias and comparison with large co-operative trials. Stat Med (1987) 6: 3152887023
- 11.Peto R, Collins R, Gray R Large-scale randomized evidence: large, simple trials and overviews of trials. Ann NY Acad Sci (1994) 703: 314
- 12.Kassirer JP Clinical trials and meta-analysis. N Engl J Med (1992) 327: 273–274161447010.1056/NEJM199207233270411
- 13.Green S, Benedetti J, Crowley J Clinical Trials in Oncology, Chapter 9 (1997) LondonChapman and Hall 167–182
- 14.Furberg CD, Morgan TM Lessons from overviews of cardiovascular trials. Stat Med (1987) 6: 2953616285
- 15.Collins R Discussion. Stat Med (1987) 6: 338
- 16.Tobias J, Houghton J, Riley DL. Moving the Goalposts-a review of clinical trial strategies in early breast cancer. In Breast Cancer-New Horizons in Research and Treatment, Chapter 17, London, Arnold, (2001) 195–202
- 17. Early Breast Cancer Trialists Collaborative Group. Treatment of early breast cancer. Vol I: Worldwide Evidence, 1985-1990, Oxford and New York, Oxford University Press, (1990)
- 18. Early Breast Cancer Trialists’ Collaborative Group Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet (1992) 339: 1–1571–85
- 19.Begg CB A measure to aid in the interpretation of publicized clinical trials. Stat Med (1985) 4: 13992068
- 20.Collins R, Gray R, Godwin J et al. Avoidance of large biases and large random errors in assessment of moderate treatment effects: the need for systematic overviews. Stat Med (1987) 2: 245
10.1002/sim.4780060308 Google Scholar
- 21.Gelber RD, Goldhirsch A The concept of an overview of cancer clinical trials with special emphasis on early breast cancer. J Clin Oncol (1986) 4: 1696–17033772421
- 22.Demets D Methods for combining randomized clinical trials: strengths and limitations. Stat Med (1987) 6: 341–3483616287
- 23.Simon R The role of overviews in cancer therapeutics. Stat Med (1987) 6: 389–3933616291
- 24.Simes RJ Publication bias: the case for an international registry of clinical trials. J Clin Oncol (1986) 4: 15293760920
- 25.Tippett LHC The Method of Statistics (1931) LondonWilliams and Norgate
- 26.Fisher RA Statistical Methods for Research Workers (1932) 4LondonOliver and Boyd
- 27.Pearson K On a method of determining whether a sample of given size n supposed to have been drawn from a parent population having a known probability integral has probably been drawn at random. Biometrika (1933) 25: 37910.2307/2332290
- 28.Fisher RA Combining independent test of significance. Am Stat (1948) 2: 3010.2307/2681650
10.2307/2681650 Google Scholar
- 29.Dersimonian R, Laird N Meta-analysis in clinical trials. Control Clin Trials (1986) 7: 177380283310.1016/0197-2456(86)90046-2
- 30.May GS, Eberlein K, Furberg G et al. Secondary prevention trials after myocardial infarction: a review. Prog Cardiovasc Dis (1982) 24: 331–352611973710.1016/0033-0620(82)90010-X
- 31.Yusuf S, Peto R, Lewis J et al. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis (1985) 27: 335–3712858114
- 32.Yusuf S, Collins R, Peto R et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomised controlled trials. Eur Heart J (1985) 6: 556–5853899654
- 33.The 2000 EBCTCG overview: a widening gap. Comment. Lancet (2005) ; 365: 1665–1666
- 34.Wittes RE Problems in the medical interpretation of overviews. Stat Med (1987) 6: 2693616283
- 35.Berlin JA, Laird NM, Sacks HS et al. A comparison of statistical methods for combining event rates from clinical trials. Stat Med (1989) 8: 1412704896
- 36.Lau J, Antman EM, Jimenez-Silva J et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. JAMA (1992) 268: 240–248153511010.1001/jama.268.2.240
- 37. Early Breast Cancer Trialists Collaborative Group Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: an overview of the randomized trials. Lancet (2005) 365: 1687–171710.1016/S0140-6736(05)66544-0
